A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections

E-ISSN： 1873-4286|22|17|2577-2598

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.17, 2016-05, pp. : 2577-2598

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contribution of Efflux Pump Activity to the Delivery of Pulmonary Therapeutics

Current Drug Metabolism, Vol. 3, Iss. 1, 2002-02 ,pp. : 1-12

Bentham Science Publishers

Access to resources Recommend Favorite

New technology for pulmonary drug delivery

By Senior K.

Pharmaceutical Science & Technology Today, Vol. 3, Iss. 8, 2000-08 ,pp. : 261-262

Elsevier

Access to resources Recommend Favorite

Delivery and performance of surfactant replacement therapies to treat pulmonary disorders

By El-Gendy Nashwa Kaviratna Anubhav Berkland Cory Dhar Prajnaparamita

Therapeutic Delivery, Vol. 4, Iss. 8, 2013-08 ,pp. : 951-980

Future Science

Access to resources Recommend Favorite

Macrophage Dysfunctions in Cystic Fibrosis Pulmonary Disease: Implications in Inflammation and Chronic Infections

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 2, 2017-08 ,pp. : 82-91

Bentham Science Publishers

Access to resources Recommend Favorite

New therapies for chronic obstructive pulmonary disease

By Krishna Ganesh Sankaranarayanan Viji Chitkara Rajinder K

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 3, 2004-03 ,pp. : 255-267

Informa Healthcare

Access to resources Recommend Favorite